A novel procedure for the determination of tricyclic antidepressants in plasma by use of high performance liquid chromatography.
A novel method for the determination of the antidepressant 3-(1-chloro-5-H-dibenzo [a,d] cycloheptene-5-ylidene)-N,N-dimethylpropylamine-N-oxide hydrochloride and its metabolites by use of high performance liquid chromatography was developed. The procedure is applicable to the assay of other similar drugs in biological samples. The method involves extraction of the unchanged drug and its metabolites from plasma, back-extraction into diluted phosphoric acid and re-extraction into an organic phase. Separation is performed on a silica gel column with an acidic mobile phase, containing sodium dodecyl sulfate as ion-pairing agent. The quantitation is carried out by UV detection. The procedure allows the determination of plasma levels down to about 5 ng/ml of the unchanged drug and its metabolites, respectively, when 1 ml of plasma is used. The plasma levels of two volunteers were determined after a single oral dose of the drug.
D000929:Antidepressive Agents, Tricyclic / Q000097:blood*; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D003986:Dibenzocycloheptenes / Q000097:blood*; D006801:Humans; D008722:Methods
D000929:Antidepressive Agents, Tricyclic; D003986:Dibenzocycloheptenes